This past month, the University of Oslo (UiO) had the privilege of participating in a symposium hosted by the Forschungscampus Mittelhessen. The two-day event, "The Intersection of Digital Technology and Patient Care," explored the dynamic fusion of digital technologies with patient care practices, emphasising the field of regenerative medicine.
The symposium kicked off on the morning of June 29th, at the Biomedical Research Center Seltersberg, with presentations from international graduate schools, including the University of Queensland, Technische Hochschule Mittelhessen (THM), and Justus Liebig University Giessen (JLU). Speakers shared insights on "International Research Training Groups" and the intersection of digital technology and patient care. Notably, Thaqif El Khassawna from JLU spoke on the transformative potential of Regenerative Medicine 2.0.
Various experts from different backgrounds also presented, including Denise Salzig from THM who discussed the development process for advanced therapy medicinal products (ATMPs) and Michael Scholtes from THM who elaborated on bio-compatible materials and tissue engineering regulations. The day culminated with a presentation from Dr. Augustine Mark Saiz Jr. from UC Davis, who spoke about how biomaterials can be used in polytrauma surgeries.
Our Håvard Haugen represented the University of Oslo on the symposium's second day. Håvard enlightened the audience with the latest research from our department, furthering UiO's contributions to the international academic community. The second day also highlighted several other presentations from representatives of different international universities and concluded with lab visits at Biomedical Research Center Seltersberg and Esculap, THM.
The symposium was a fine opportunity for academics and professionals to engage in thought-provoking discussions about the future of patient care in the era of digital technology. The symposium also marked the final for our PhD student Øystein Øvrebø's 2-month stay at the University of Giessen supported by UiO@LifeScience. We are happy about the contributions made by our UiO representatives and look forward to the new collaborations and advancements these actions will undoubtedly inspire.
Our participation in this symposium is a testament to the University of Oslo's commitment to pushing the boundaries of digital health, combining technology with patient care, and our dedication to improving global health outcomes.